1
In contrast to acquired anosmia, congenital anosmia is a relatively rare condition characterised by a complete lack of olfactory perception and the aplasia or hypoplasia of the olfactory bulb. Kallmann syndrome (congenital hypogonadotropic hypogonadism and anosmia) is the best known condition associated with congenital anosmia. 2, 3 Kallmann syndrome has a prevalence of around 1 in 8000 and is five times more common in men than in women. 2, 3 Correspondence: J. Powell 
Methods

Ethical considerations
The study was registered with the Newcastle upon Tyne Hospitals NHS Foundation Trust Audit Department.
Case note and radiology review
We retrospectively reviewed the notes and scans of patients identified as having the diagnosis of congenital anosmia over the last 10 years (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) . Patients were identified through rigorous searching of radiology and medical coding data. All patients presented to the Department of Otolaryngology-Head and Neck Surgery, Newcastle upon Tyne. Radiology images were all reported by the same specialist head and neck consultant radiologist.
Results
Case note review
We identified 230 patients during the 10-year period with clinician-diagnosed olfactory dysfunction as a primary complaint and who underwent MR scanning to investigate this. Of those, 11 (5%) patients had a clinical history and radiological evidence confirming congenital anosmia (six males and five females). In the congenital anosmia cohort, the median age at presentation was 19 years (range 7-42 years). Only three of 11 patients presented to Department of Otolaryngology in childhood (16 years or younger). Only one patient was found to have Kallmann syndrome, and the rest of the cohort (10 of 11) had no associated comorbidities. All patients described anosmia since early memory. A thorough medical history, physical examination and nasal endoscopy were performed in all cases. All patients were sent for an MRI as the primary imaging modality.
Radiology review
All patients underwent an MRI at the Freeman Hospital, Newcastle upon Tyne, on either 1.5T Avanto or Symphony machine (Siemens, Erlangen, Germany). The standard protocol for scanning at our hospital includes 5 mm axial T2 images through the whole brain to exclude any abnormality (such as meningioma or post-traumatic gliosis) in the anterior cranial fossa and 3 mm coronal T1, T2 and FLAIR (fluid-attenuated inversion recovery) sequences to specifically look at the olfactory bulbs and tracts and sinonasal tract. Volumetric studies such as VIBE (volume interpolated brain examination) and DRIVE (driven equilibrium) sequences allow the acquisition of thinner slices but because of longer scanning times are sometimes prone to movement artefact and not used routinely in our practice.
MRI demonstrated complete absence of the olfactory sulci, bulbs and tracts in eight patients (see Figs 1 and 2 ) and hypoplasia in three others. Vestigial olfactory sulci were always present in patients with hypoplastic olfactory bulbs and tracts and generally easier to identify than the Correspondence 1039 olfactory bulbs and tracts. It is therefore recommended that the olfactory sulci should be the first structure to be identified when interpreting MR images. Olfactory sulci can be identified on both the axial and the coronal images, but the olfactory bulbs and tracts are best seen on the coronal images.
Discussion
Synopsis of key findings
Congenital anosmia is a rare condition making up only 5% (11 of 230) of cases of olfactory dysfunction in our unit over a 10-year period. Congenital anosmia was found to be an isolated diagnosis in most patients, only one of 11 patients in our case series had Kallmann syndrome. We also demonstrated that most patients with congenital anosmia presented to ENT services in adulthood with a long history of anosmia.
Strengths and weaknesses of the study
This is a relatively small case series; however, given the rarity of this condition, this is to be expected. It is possible that some cases were missed due to coding errors; however, we rigorously searched both clinical coding records and radiology coding records to minimise this. None of the patients in our cohort had objective tests for anosmia. In keeping with the majority of UK ENT departments, we do not routinely perform psychophysical assessments of olfaction in our unit. However, all patients gave a clear history of anosmia present since early memory and had imaging confirming olfactory tract abnormalities; therefore. we feel this is diagnostic and fits in with clinical practice in the majority of units.
Comparisons with other studies
Several other small case series have described congenital anosmia. [4] [5] [6] [7] Given the rarity of this condition, the addition of further retrospective data is required to allow future pooling of the clinical data and analysis.
Clinical applicability of the study
This study demonstrates the experiences of congenital anosmia in one large teaching hospital in the UK over a 10-year period. We present the clinical and radiological findings one would expect in these patients to aid clinical identification and appropriate imaging in patients presenting with suspected congenital anosmia. Currently, there is no cure available for anosmia; in such cases, however, patients should be counselled to ensure safety with smoke and gas alarms, as well as ensuring that perishable foods are labelled to minimise risks of illness from ingestion of spoiled food.
Keypoints
• Congenital anosmia is a rare condition; only 5% of cases of olfactory dysfunction seen in our unit over a 10-year period were congenital.
• Most cases of congenital anosmia in our series presented as an isolated phenomenon in adulthood.
• While there is no available cure, identification of these patients is important to ensure appropriate counselling.
• All cases of anosmia reported since birth should have an MRI scan performed to identify an absent or hypoplastic olfactory tract.
